SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-069917
Filing Date
2023-06-09
Accepted
2023-06-09 16:17:05
Documents
14
Period of Report
2023-06-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2318211d1_8k.htm   iXBRL 8-K 45744
2 EXHIBIT 3.1 tm2318211d1_ex3-1.htm EX-3.1 6462
3 EXHIBIT 99.1 tm2318211d1_ex99-1.htm EX-99.1 79158
  Complete submission text file 0001104659-23-069917.txt   331752

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA carm-20230606.xsd EX-101.SCH 3036
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE carm-20230606_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE carm-20230606_pre.xml EX-101.PRE 22597
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2318211d1_8k_htm.xml XML 3719
Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 231005512
SIC: 2834 Pharmaceutical Preparations